
    
      Participants will be required to make four visits for evaluation. Visit 1 is a screening
      visit, participants will receive the study drug or a placebo during visits 2 and 3, and visit
      4 is a follow up visit. Participants will provide blood and urine samples during the visits.
      Participants will also be required to complete questionnaires and a series of motor tests.
    
  